People who have had the herpes virus at some point in their lives are twice as likely to develop dementia compared to those who have never been infected.
Novel Weekly Oral HIV Drug Safe in Early Trial of Healthy Volunteers
Data from a phase Ia clinical trial of an oral, long-acting integrase inhibitor (GS-1720) in development for HIV demonstrated promising safety in healthy adults without
November 14, 2024